121409-13-0

Upstream product

• 121409-21-0 2,4,5,7,8,9-hexa-O-acetyl-3-deoxy-D-glycero-D-galacto-2-nonulopyranosylonic acid 
• 100-39-0 benzyl bromide 
• 121409-12-9 benzyl 2,4,5,7,8,9-hexa-O-acetyl-3-deoxy-D-glycero-β-D-galacto-2-nonulopyranosonate 
• 908094-04-2 phenyldiazomethane 

Downstream Products

• 121409-22-1 benzyl 4,5,7,8,9-penta-O-acetyl-2,6-anhydro-2,3-dideoxy-D-glycero-D-galacto-non-2-enonate 
• 121409-17-4 benzyl 4,5,7,8,9-penta-O-acetyl-2-(5-cholesten-3β-yloxy)-3-deoxy-D-glycero-β-D-galacto-2-nonulopyranosonate 
• 121409-17-4 benzyl 4,5,7,8,9-penta-O-acetyl-2-(5-cholesten-3β-yloxy)-3-deoxy-D-glycero-α-D-galacto-2-nonulopyranosonate 
• 121409-15-2 benzyl (methyl 3-deoxy-D-glycero-α-D-galacto-2-nonulopyranosid)onate 
• 121409-14-1 benzyl (methyl 4,5,7,8,9-penta-O-acetyl-3-deoxy-D-glycero-α-D-galacto-2-nonulopyranosid)onate 

Relevant academic research and scientific papers

Lipid A and related compounds. XXVI. Syntheses of biologically active penta-O-acetyl-N-glycoloylneuraminyl- and penta-O-acetyl-3-deoxy-D-glycero-D-galacto-2-nonulopyranosonic acid-(α 2 → 6)-D-glucosamine-4-phosphate analogs of lipid A

The syntheses of novel penta-O-acetyl-N-glycoloylneuraminyl- and penta-O-acetyl-3-deoxy-n-glycero-D-galacto-2-nonulopyranosonic acid-(α 2 → 6)-D-glucosamine-4-phosphate analogues of lipid A containing sialic acid in place of 3-deoxy-D-manno-2-octulosonic acid are described. Preliminary examination of the biological activity revealed that two synthetic disaccharides showed mitogenic activities and weak antitumor activities.

Studies on Sialic Acids. XV. Synthesis of α- and β-O-Glucosides of 3-Deoxy-D-glycero-D-galacto-2-nonulopyranosonic Acid (KDN)

3-Deoxy-D-glycero-D-galacto-2-nonulopyranosonic acid (KDN) was synthesized by base-catalyzed condensation in good yield.Furthermore, benzyl (methyl 3-deoxy-D-glycero-α-D-galacto-2-nonulopyranosid)onate and sodium 2-(5-cholesten-3β-yloxy)-3-deoxy-D-glycero